The protective effects of metformin in an in vitro model of aging 3T3 fibroblast under the high glucose conditions
暂无分享,去创建一个
M. Tuncdemir | S. Cinar | S. Solakoğlu | Sibel Doğan | T. Soydas | G. Kanigur Sultuybek | Elif Yaprak Saraç | Tugba Soydas
[1] K. Mizutani,et al. Impact of diabetes on gingival wound healing via oxidative stress , 2017, PloS one.
[2] M. Rinnerthaler,et al. Oxidative Stress in Aging Human Skin , 2015, Biomolecules.
[3] B. Shi,et al. Metformin Rescues the MG63 Osteoblasts against the Effect of High Glucose on Proliferation , 2014, Journal of diabetes research.
[4] M. Chang,et al. Inhibitory effect of Astragalus membranaceus root on matrix metalloproteinase‐1 collagenase expression and procollagen destruction in ultraviolet B‐irradiated human dermal fibroblasts by suppressing nuclear factor kappa‐B activity , 2013, The Journal of pharmacy and pharmacology.
[5] P. Galéra,et al. NF-κB accumulation associated with COL1A1 transactivators defects during chronological aging represses type I collagen expression through a -112/-61-bp region of the COL1A1 promoter in human skin fibroblasts. , 2012, The Journal of investigative dermatology.
[6] Xuan Wang,et al. Protective Effects of Salvianolic Acid B on Schwann Cells Apoptosis Induced by High Glucose , 2012, Neurochemical Research.
[7] F. Maquart,et al. The p65 Subunit of NF-κB Inhibits COL1A1 Gene Transcription in Human Dermal and Scleroderma Fibroblasts through Its Recruitment on Promoter by Protein Interaction with Transcriptional Activators (c-Krox, Sp1, and Sp3)* , 2011, The Journal of Biological Chemistry.
[8] Z. Werb,et al. Extracellular matrix degradation and remodeling in development and disease. , 2011, Cold Spring Harbor perspectives in biology.
[9] Xulei Tang,et al. Metformin reverses the deleterious effects of high glucose on osteoblast function. , 2010, Journal of diabetes and its complications.
[10] A. Cortizo,et al. Metformin Reverts Deleterious Effects of Advanced Glycation End-Products (AGEs) on Osteoblastic Cells , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[11] S. Vehid,et al. Metformin does not prevent DNA damage in lymphocytes despite its antioxidant properties against cumene hydroperoxide-induced oxidative stress. , 2006, Mutation research.
[12] N. Wiernsperger,et al. Generation of Reactive Oxygen Species by Endothelial and Smooth Muscle Cells: Influence of Hyperglycemia and Metformin , 2006, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[13] Kela Liu,et al. Ellagic and tannic acids protect newly synthesized elastic fibers from premature enzymatic degradation in dermal fibroblast cultures. , 2006, The Journal of investigative dermatology.
[14] James Varani,et al. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. , 2006, The American journal of pathology.
[15] G. Rutter,et al. Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. , 2005, Diabetes.
[16] A. Oikarinen. Connective tissue and aging , 2004 .
[17] M. Spies,et al. Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts. , 2003, Burns : journal of the International Society for Burn Injuries.
[18] R. Visse,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[19] A. Barden,et al. Advanced Glycation End Products: A Review , 2013 .
[20] A. Baker,et al. Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts. , 1999, Biochemical and biophysical research communications.
[21] D. Brenner,et al. NF-kappaB inhibits expression of the alpha1(I) collagen gene. , 1999, DNA and cell biology.
[22] C. Borchiellini,et al. Effect of high-glucose concentrations on the expression of collagens and fibronectin by fibroblasts in culture , 1998, Experimental Gerontology.
[23] R. Trevisan,et al. Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. , 1997, Journal of the American Society of Nephrology : JASN.
[24] V. Monnier,et al. The Mechanism of Collagen Cross-Linking in Diabetes: A Puzzle Nearing Resolution , 1996, Diabetes.
[25] C. Figarella,et al. Pancreatic Regenerating Gene Overexpression in the Nonobese Diabetic Mouse During Active Diabetogenesis , 1996, Diabetes.
[26] T. Lyons,et al. Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aging a , 1992, Annals of the New York Academy of Sciences.
[27] B. Willershausen-Zönnchen,et al. Influence of high glucose concentrations on glycosaminoglycan and collagen synthesis in cultured human gingival fibroblasts. , 1991, Journal of clinical periodontology.
[28] R. Duthie. Connective Tissue and Ageing , 1974 .
[29] A. Bilir,et al. Differences between Solution and Membrane Forms of Chitosan on the In Vitro Activity of Fibroblasts. , 2015, Balkan medical journal.
[30] A. Çurgunlu,et al. Does metformin prevent short term oxidant-induced DNA damage? In vitro study on lymphocytes from aged subjects , 2007, Journal of basic and clinical physiology and pharmacology.
[31] N. Perkins,et al. Regulation of NF-kappaB function. , 2006, Biochemical Society symposium.
[32] N. Wiernsperger. Metformin: intrinsic vasculoprotective properties. , 2000, Diabetes technology & therapeutics.
[33] H. Hatemi,et al. The Effect of Metformin on Insulin Receptors and Lipid Peroxidation in Alloxan and Streptozotocin Induced Diabetes , 1995, Journal of basic and clinical physiology and pharmacology.
[34] R. Bucala,et al. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. , 1992, Advances in pharmacology.